Skip to main content
. 2019 Oct 1;58(19):2759–2766. doi: 10.2169/internalmedicine.2754-19

Table 4.

Incidence of Bleeding after ESD in the Treatment Groups according to Each Variable.

PPI group
71 patients
VPZ group
59 patients
p
Tumor location Body 5/40 (13%) 6/32 (19%) 0.53
Antrum 4/31 (13%) 11/27 (41%) 0.06
Number of tumors Single 6/53 (11%) 9/40 (23%) 0.22
Multiple 3/18 (17%) 8/19 (42%) 0.20
Curability Curative 7/54 (13%) 14/53 (26%) 0.15
Noncurative 2/17 (12%) 3/6 (50%) 0.14

ESD: endoscopic submucosal dissection, VPZ: vonoprazan, PPI: proton-pump inhibitor